Citalopram
- Product NDC
- 60429-174
- Requested package NDC
- 60429-174-10
- 11-digit product format
- 604290174
- Labeler code
- 60429
- Product ID
- 60429-174_e5feec09-73b9-e4c0-e053-2995a90a3025
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA077045
- Marketing category
- ANDA
- Marketing start
- 2005-04-29
- Marketing end
- 0000-00-00
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 60429-174 | 60429-174-10 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077045-001 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2005-04-29 | |
| A077045-002 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2005-04-29 | |
| A077045-003 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2005-04-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077045-001 | AB |
| A077045-002 | AB |
| A077045-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077045-001 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2005-04-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077045-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2005-04-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077045-003 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2005-04-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077045-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077045-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077045-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CITALOPRAM | CITALOPRAM | Golden State Medical Supply, Inc. | f3a26d92-b662-4896-82eb-261948042408 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | 077045 ANDA077045 60429-174-10 60429-174 60429017410 |
| CITALOPRAM | CITALOPRAM | Epic Pharma, LLC | 08b6d5da-5919-4760-9e16-3b478a14d6d7 | 2024-09-18 | Boxed warning, Warnings, Adverse reactions | 077045 ANDA077045 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 | 2020-05-13 | Boxed warning, Warnings, Adverse reactions | 077045 ANDA077045 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 475812f9-1b2c-4cb0-9e72-1e52f935ae6f | Product name | 1 | 20221114 |
| 0b05d650-9b7b-4b36-a6f4-1a850d5a2e64 | Product name | 1 | 20151228 |
| e61ea6cb-0b08-40a9-a984-7b23201c7aa2 | Product name | 1 | 20151222 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60429-174-01 | CITALOPRAM | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 13 | |
| 60429-174-10 | CITALOPRAM | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 13 | |
| 60429-174-30 | CITALOPRAM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60429-174-01 | EA - Each | 60429-174 | c9205fee-f9fb-4f30-864f-8809bc8fba5e | 1 | 2012-07-24 |
| 60429-174-10 | EA - Each | 60429-174 | 1501b26e-c321-42f3-a938-31a35b6f9eeb | 1 | 2012-07-24 |
| 60429-174-30 | EA - Each | 60429-174 | f8964d94-1eeb-42ff-aac9-9f961915104e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CITALOPRAM HYDROBROMIDE | ACTIVE INGREDIENT | I1E9D14F36 | CITALOPRAM TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| CITALOPRAM | ACTIVE MOIETY | 0DHU5B8D6V | CITALOPRAM TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 283672 | citalopram 10 MG Oral Tablet | PSN | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 200371 | citalopram 20 MG Oral Tablet | PSN | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 309314 | citalopram 40 MG Oral Tablet | PSN | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 283672 | citalopram 10 MG Oral Tablet | SCD | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 200371 | citalopram 20 MG Oral Tablet | SCD | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 309314 | citalopram 40 MG Oral Tablet | SCD | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 283672 | citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet | SY | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 200371 | citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet | SY | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 309314 | citalopram 40 MG (as citalopram HBr 49.98 MG) Oral Tablet | SY | f3a26d92-b662-4896-82eb-261948042408 | 13 |
| 200371 | citalopram 20 MG Oral Tablet | PSN | 2fae4dd4-e4ca-4237-aab8-4079856d6bb0 | 2 |
| 200371 | citalopram 20 MG Oral Tablet | SCD | 2fae4dd4-e4ca-4237-aab8-4079856d6bb0 | 2 |
| 200371 | citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet | SY | 2fae4dd4-e4ca-4237-aab8-4079856d6bb0 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60429-174-10 | 60429017410 | 1000 TABLET, FILM COATED in 1 BOTTLE (60429-174-10) | 2011-05-20 | 0000-00-00 | No | No | Current |